Pfizer profits $ 2.33 billion in the first quarter, down 15%

NEW YORK-u.s. drugmaker Pfizer announced on Monday, 5, net income 15% lower in the first quarter of this year, from $ 2.33 billion. In the same period in 2013 the net profit stood at $ 2.75 billion. In the same comparison, the gain per share shrank to $ 0.36, from 38 cents. Considering adjustments, however, earnings per share rose to $ 0.57, $ 0.51. Revenue declined 8.5 percent, to $ 11.35 billion.
The adjusted profit came in above expectations, but revenue fell short of expectations. Analysts queried by Thomson Reuters expected adjusted earnings per share of $ 0,55 and sales of $ 12.08 billion. Around 8:25 (Eastern), shares of Pfizer fell 0.81% in pre-market on New York.
The recipe of the pharmaceutical business of Pfizer fell 13 percent, to $ 5.99 billion, while the global segment of pharmaceutical innovation had fallen 7%, to $ 3.08 billion. Spending on research and development, in turn, decreased 5.1% in the first quarter compared with a year earlier. Source: Dow Jones Newswires.